Skip to main content
. 2016 Dec 5;355:i6253. doi: 10.1136/bmj.i6253

Table 4.

Comparing current guidelines with risk prediction model

Statistics English data: total No postpartum women=433 353; total No VTE events=312 (imputed results) Swedish data: total No pregnancies=662 387; total No VTE events=521 (imputed results)
Women given thromboprophylaxis based on RCOG postnatal thromboprophylaxis guidelines* Risk prediction model (England): top 35% cut-off (threshold=6.3 per 10 000 deliveries) Women given thromboprophylaxis based on Swedish national guidelines† Risk prediction model (Sweden): top 6% cut-off (threshold=18 per 10 000 deliveries) Risk prediction model (Sweden): top 35% cut-off (threshold=7.2 per 10 000 deliveries)
Total No (%) postpartum women warranting thromboprophylaxis 149 402 (34.5) 149 402 (34.5) 41 254 (6.2) 41 254 (6.2) 231 835 (35)
Observed VTE events‡ 197 212 109 158 355
Mean predicted risk per 10 000 pregnancies 12.3 13.0 25.8 31.6 14.2
Sensitivity§, % (95% CI) 63.1 (57.5 to 68.5) 67.9 (62.5 to 73.1) 20.9 (17.5 to 24.7) 30.3 (26.4 to 34.5) 68.1 (63.9 to 72.1)
Positive predictive value¶, % (95% CI) 0.13 (0.11 to 0.15) 0.14 (0.12 to 0.16) 0.26 (0.21 to 0.31) 0.38 (0.32 to 0.45) 0.15 (0.13 to 0.17)
Specificity**, % (95% CI) 65.6 (65.4 to 65.7) 65.6 (65.4 to 65.7) 93.8 (93.7 to 93.8) 93.8 (93.7 to 93.9) 65.1 (64.9 to 65.2)

*Women with either two low risk factors (varicose veins, age >35 years, overweight, body mass index (BMI) 30-39, parity ≥3, smoker, puerperal infection, elective caesarean section, multiple delivery, preterm birth, stillbirth, pre-eclampsia/eclampsia, or postpartum haemorrhage) or one high risk factor (comorbidities (inflammatory bowel disease (IBD), heart disease, kidney disease), BMI ≥40, or emergency caesarean section)).

†Women with two clinical risk factors (elective caesarean section, age ≥40 years, BMI ≥30, or any comorbidities (heart disease, IBD, or kidney disease)).

‡In women warranting thromboprophylaxis.

§Percentage of true positive venous thromboembolism (VTE) cases correctly identified on basis of current thromboprophylaxis guidelines/risk prediction model.

¶Percentage of women without VTE diagnosis correctly identified on basis of thromboprophylaxis guidelines/risk prediction model.

**Likelihood that women above treatment threshold will develop VTE.